Skip to main content
Full access
Articles
Published Online: 15 April 2016

Hyperresponsiveness of the Neural Fear Network During Fear Conditioning and Extinction Learning in Male Cocaine Users

Abstract

Objective:

The authors investigated whether cocaine use disorder is associated with abnormalities in the neural underpinnings of aversive conditioning and extinction learning, as these processes may play an important role in the development and persistence of drug abuse.

Method:

Forty male regular cocaine users and 51 male control subjects underwent a fear conditioning and extinction protocol during functional MRI. Skin conductance response was measured throughout the experiment as an index of conditioned responses.

Results:

Cocaine users showed hyperresponsiveness of the amygdala and insula during fear conditioning, as well as hyporesponsiveness of the dorsomedial prefrontal cortex during extinction learning. In cocaine users, but not in control subjects, skin conductance responses were positively correlated with responsiveness of the insula, amygdala, and dorsomedial prefrontal cortex during fear conditioning but negatively correlated with responsiveness of the ventromedial prefrontal cortex during extinction learning.

Conclusions:

Increased sensitivity to aversive conditioned cues in cocaine users might be a risk factor for stress-relief craving in cocaine use disorder. These results support the postulated role of altered aversive conditioning in cocaine use disorder and may be an important step in understanding the role of aversive learning in the pathology of cocaine use disorder.
Cocaine is the second most commonly used illicit drug in Europe, particularly among young adult males, and it is often used in combination with alcohol and cannabis (1). There are no registered pharmacological treatments for cocaine addiction (2), although cognitive-behavioral therapy and contingency management have been shown to be fairly successful (3). Learning processes, including Pavlovian and instrumental conditioning, play an essential role in the development and persistence of substance use disorder (4). While these learning processes may form a potential treatment target (5), psychotherapies targeting conditioning have not yet been shown to be effective (6). A possible reason is that previous research has focused primarily on the learning mechanisms underlying appetitive conditioning (cue exposure treatment), while aversive conditioning may be equally important in the etiology and treatment of cocaine use disorder.
Through the process of appetitive conditioning, drug responses become associated with drug-related cues. When these drug-related cues are subsequently encountered in an abstinent state, they can trigger the retrieval of memories of previous drug experiences and thereby induce cue reactivity, craving, and drug-seeking and drug-taking behavior (7, 8). However, there is increasing evidence that aversive conditioning plays an equally important role in substance use disorder (9). First, stress-induced relief craving is a frequently observed phenomenon in addiction (10, 11), and addicted individuals are thought to take drugs to avoid aversive states such as stress (12, 13). Through the process of aversive conditioning, external stimuli can become associated with internal stress states, thereby (indirectly) motivating drug-seeking and drug-taking behavior itself (5, 14). Second, there is a high comorbidity between anxiety disorders and substance use disorder (15). Since abnormalities in aversive conditioning and extinction learning have been reported in anxiety disorders (16), similar abnormalities are expected to be found in substance use disorder. And third, the neural underpinnings of aversive and appetitive conditioning are thought to largely overlap, since the mesolimbic dopamine system is a key player in both types of conditioning and extinction learning (9). As a consequence, neuroadaptive changes within the mesolimbic dopamine system due to stress or drug use may also modulate the processing of appetitive conditioning or aversive conditioning, respectively (1719). Knowledge about the role of aversive conditioning in substance use disorder could thus have important implications for understanding its pathophysiology and the development of prevention and treatment strategies. However, so far no studies have been reported on the neural and physiological underpinnings of aversive conditioning in substance use disorder.
From studies in healthy individuals, we know that aversively conditioned stimuli evoke an increase in skin conductance response (20) and activation of the neural fear network, including the amygdala, dorsomedial prefrontal cortex, and insula, and deactivation of the ventromedial prefrontal cortex (21, 22). Within this network, the amygdala, dorsomedial prefrontal cortex, and insula are involved in the expression of aversive conditioned responses, while the ventromedial prefrontal cortex is involved in the inhibition of conditioned behavior (21, 23, 24). Anxiety disorders are characterized by hyperresponsiveness of the amygdala, dorsomedial prefrontal cortex, and insula during fear learning and hyporesponsiveness of the ventromedial prefrontal cortex during extinction learning, reflecting the presence of enhanced fear learning and impaired fear extinction capabilities (25). Counterintuitively, these differences in neural plasticity are typically not associated with enhanced differential skin conductance responses (16, 26, 27).
In this study, we investigated the physiological (skin conductance responses) and neural (regional brain activation) correlates of fear conditioning and extinction in cocaine abusers and non-drug-using control subjects. While the neural and physiological underpinnings of aversive conditioning and extinction learning have not yet been investigated in substance use disorder, previous studies have demonstrated that substance use disorder is associated with hyperresponsiveness of the dorsomedial prefrontal cortex, insula, and amygdala to conditioned drug cues, a response that is slowly extinguished (6). We therefore hypothesized that cocaine abuse is associated with enhanced fear conditioning and impaired extinction learning, as reflected by hyperactivation of the amygdala, insula, and dorsomedial prefrontal cortex during fear conditioning and hypoactivation of the ventromedial prefrontal cortex during extinction learning as compared with control subjects.

Method

Participants

Seventy male regular cocaine users and 73 male control subjects were included in this study. Complete skin conductance response and MRI data sets were collected from 53 cocaine users and 58 control subjects. An additional three cocaine users and four control subjects were excluded because of MRI artifacts, resulting in the inclusion of 48 cocaine users and 54 control subjects. Participants were 18–50 years of age, and were recruited through local advertisements in the greater Amsterdam area. Cocaine users had to be actively using cocaine (at least once per week for a minimum of 6 months) and currently non–treatment seeking. Participants were screened using the Mini International Neuropsychiatric Interview (28). Exclusion criteria for all participants were major medical or neurological disease, a lifetime history of psychotic or bipolar disorders, current use of antidepressants or antipsychotics, and any contraindication for MRI scanning. Control subjects were excluded if they met DSM-IV criteria for lifetime substance abuse or dependence or currently took any psychotropic medications other than antidepressants or antipsychotics. Alcohol, cocaine, and cannabis use in the previous 6 months was quantified using the timeline followback procedure (29). Smoking severity was measured using the Fagerström Test for Nicotine Dependence, state anxiety was measured with the State-Trait Anxiety Inventory (30), and premorbid verbal intelligence was estimated using the Dutch version of the National Adult Reading Test (31). The study was approved by the Ethical Review Board of the Academic Medical Center of the University of Amsterdam. All participants gave written informed consent.

Experimental Paradigm

Briefly, the classical fear conditioning paradigm, which was conducted in the MRI scanner, consisted of habituation, conditioning, and extinction phases. The conditioned stimuli (CS) were yellow and blue squares, of which one (CS+) was followed by the unconditioned stimulus (US) in 33% of the conditioning trials. The CS− was never followed by the US. The US was an aversive electrical shock to the wrist. The shock intensity was set individually to be highly annoying but not painful. Skin conductance responses were measured simultaneously with functional MRI (fMRI) acquisition. Additional details are provided in the data supplement that accompanies the online edition of this article.

Imaging Data Acquisition and Analysis

Images were acquired on a 3-T Philips Achieva scanner and analyzed using SPM8 (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/), including standard preprocessing and first-level modeling (see the data supplement). In accordance with previous studies, first-level contrasts were computed for the CS+ (unpaired to the US) and the CS− during the early and late conditioning phases and early and late extinction phases in order to assess temporal gradation of signal intensity (22). Early and late phases included the first and the last half of the CS+ and CS− trials, respectively. These contrast images were entered into a second-level full factorial design to investigate task and group effects.
A whole-brain correlation analysis was performed to investigate whether individual differences in conditioned responses measured by skin conductance and neural responses by fMRI were associated and whether these correlations during fear conditioning and extinction learning differed between groups. An additional whole-brain correlation analysis was performed to test for the possible confounding effects of state anxiety, amount and type of substance use, and days since last use (see the online data supplement).
All analyses were family-wise-error-rate-corrected for multiple comparisons (cluster p<0.05, height threshold p<0.01). A small-volume correction was applied for the amygdala (p<0.05) because of its a priori role in aversive conditioning. With regard to the correlation analyses, interactions that assessed group differences in correlations were tested and followed by within-group correlation analyses when significant.

Statistical Analysis

Group differences in clinical characteristics were assessed using independent-samples t tests or nonparametric tests when appropriate. Stimulus-induced skin conductance responses were defined as the difference between maximum and minimum responses within 8 seconds after CS onset. Responses were divided by the largest response for that individual to account for individual differences and square-root-transformed (+1) to normalize the data. Subjects were said to show conditioned responses when differential skin conductance responses were positive in the first or second half of the conditioning phase. A repeated-measures analysis of variance was used, including CS type (CS+, CS−), phase (conditioning, extinction), and time (early, late) as within-subject factors, and group (controls, cocaine users) as a between-subject factor.

Results

Clinical Characteristics

To enable the assessment of extinction learning, successful acquisition of fear conditioning is required. Of all subjects, 40 cocaine users (83%) and 51 control subjects (94%) showed a positive differential skin conductance response during early or late conditioning, which was not a statistically significant difference. In line with previous studies, the nonconditioners were excluded based on these physiological data (22), and all further analyses were conducted on the remaining subsamples (cocaine users, N=40; control subjects, N=51). The two groups were of similar age and IQ, but cocaine users scored significantly higher on state anxiety and weekly alcohol intake and had more comorbid DSM-IV diagnoses of depression and anxiety disorders (Table 1). On average, cocaine users used 7.6 g on 8.7 separate days on a monthly basis and had an onset age of 19.4 years, an average of 8.8 years of cocaine use, and 3 days since last use. All cocaine users met DSM-IV criteria for cocaine dependence or abuse. In addition, 86% of the cocaine users also smoked tobacco, and 45% used cannabis at least once a week.
TABLE 1. Demographic and Clinical Characteristics of Regular Cocaine Users and Control Subjects
VariableCocaine Users (N=40)Control Subjects (N=51)p
 MeanSDMeanSD 
Age (years)31.37.931.08.5n.s.
IQ101.48.4104.09.2n.s.
Alcohol use (standard units per week)19.935.44.13.5<0.001
 MedianIQRMedianIQR 
Fagerström Test for Nicotine Dependence5.02.0   
Grams of cocaine use per month7.65.5   
Duration of cocaine use (years)8.86.4   
Frequency of cocaine use (days/month)8.75.8   
Age at onset of cocaine use (years)19.45.1   
Days since last use3.02.0   
State anxiety score (State-Trait Anxiety Inventory)35.017.028.07.0<0.001
Shock intensity (mA)2.81.42.41.8n.s.
 N%N% 
Smoker3486.000.0<0.001
Lifetime history of DSM-IV depression1332.535.90.002
Lifetime history of a DSM-IV anxiety disorder410.000.00.032

Physiology

The median shock intensity did not differ significantly between groups (cocaine users, 2.8 mA; control subjects, 2.4 mA). The skin conductance response during conditioning and extinction revealed a significant CS type-by-phase interaction (F=10.78, df=3, 87, p<0.001). As expected, because of the exclusion of participants who did not show successful fear conditioning, paired-sample t tests revealed that both groups showed a significant CS+/CS− difference on skin conductance responses during early conditioning (t=4.62, df=90, p<0.001) and late conditioning (t=7.39, df=90, p<0.001), but also during early extinction (t=3.24, df=90, p=0.002). No significant CS+>CS− differences in skin conductance response were observed during late extinction, indicating successful extinction learning. Similar to previous findings in anxiety disorders, there was no significant group-by-CS type-by-phase interaction, indicating equal levels of fear conditioning and extinction learning between groups on a physiological level (Figure 1).
FIGURE 1. Mean Skin Conductance Response in Cocaine Users and Control Subjectsa
a Error bars indicate standard deviation. There was a significant differential skin conductance response during early and late conditioning and early extinction, in both groups. No significant group differences in skin conductance response were demonstrated.

Neuroimaging

The four-way interaction between group, phase, time, and CS type was nonsignificant. Because fear conditioning and extinction are qualitatively distinct processes and neural responses during fear learning show a strong temporal gradation in signal intention, group differences in fear learning were investigated for each phase separately, in line with previous studies (e.g., 22, 32).

Fear conditioning.

During fear conditioning, both groups displayed significant activation in the neural fear network for the CS+>CS− contrast, including the insula, dorsomedial prefrontal cortex, amygdala, and superior temporal cortex (see Table S1 in the online data supplement), reflecting fear conditioning on the neural level. Between-group analysis revealed that, compared with control subjects, cocaine users exhibited recruitment of the left amygdala and several cerebellar and occipital regions during early conditioning (Figure 2A, Table 2) and enhanced recruitment of the left insula and rolandic operculum during late conditioning (Figure 2B, Table 2). These results are consistent with the hypothesis that cocaine users exhibit neural hyperresponsivity during fear conditioning.
FIGURE 2. Neural Correlates of Aversive Conditioning and Correlation With Skin Conductance Responses in Cocaine Users and Control Subjectsa
a Cocaine users exhibited hyperactivation of the left amygdala (panel A) and left insula (panel B) during early conditioning and late conditioning, respectively. The correlation between skin conductance responses and activation of the neural fear network was significantly stronger in cocaine users compared with control subjects (panel C). The scatterplot shows, for all subjects, the beta weight of the peak voxel in the amygdala (Montreal Neurological Institute coordinates [x, y, z]: 30, −4, 28) as a result of the whole brain comparison, against the differential skin conductance responses during early conditioning.
TABLE 2. Neural Correlates of Aversive Conditioning and Extinction Group Effects and Interactions With Skin Conductance Responsesa
EffectCluster Size (Voxels)Cluster pVoxel zPeak Voxel MNI CoordinatesVoxel RegionDirection of Effect
Early conditioning (CS+>CS−)        
Group effects1,0320.0163.48–2–50–6VermisCU > HC
   3.07–6–522L lingual gyrus 
   2.69–2–4818L posterior cingulate gyrus 
   3.022–4416R posterior cingulate gyrus 
   2.98–4–74–24L cerebellum 
   2.66–10–5016L precuneus 
 450.022b3.15–300–22L amygdalaCU > HC
Group-by-skin conductance response interaction36,333<0.0015.2738–3058R postcentral gyrusCUc / HCd
   5.14–26–2058L precentral gyrus 
   5.2438–2056R precentral gyrus 
   4.9424054R superior frontal gyrus 
   4.844–2246R middle cingulate gyrus 
   4.664–3260R paracentral lobule 
   4.6544–2214R Heschl’s gyrus 
   4.61–18–42–28L cerebellum 
 7210.0374.85424810R middle frontal gyrusCUc / HCd
   3.064634–6R inferior frontal gyrus 
 6870.0454.49–404422L middle frontal gyrusCUc / HCd
   3.65–403022L inferior frontal gyrus 
   3.24–265810L superior frontal gyrus 
 1390.0014.0730–4–28R amygdalaCUc / HCd
Late conditioning (CS+>CS−)        
Group effects9150.0293.87–42–216L rolandic operculumCU > HC
   3.61–36016L insula 
Group-by-skin conductance response interactionNo significant interaction
Early extinction (CS+>CS−)        
Group effectsNo significant effects
Group-by-skin conductance response interaction1,3680.0043.92–10480L anterior cingulate gyrusCUe / HCd
   3.91–2828–14L inferior frontal gyrus 
   3.90–12466L superior frontal gyrus 
   3.141044–8R orbital frontal gyrus 
Late extinction (CS+>CS−)        
Group effects4,691<0.0014.58–10862L superior motor areaHC > CU
   3.99143620R anterior cingulate gyrus 
   3.78–40252L middle frontal gyrus 
   3.63102254R superior motor area 
   3.39182646R superior frontal gyrus 
         
Group-by-skin conductance response interaction3,060<0.0014.49–52–26L rolandic operculum 
   3.71–44–1410L Heschl’s gyrus 
   3.63–50–2428L postcentral gyrus 
   3.59–52–2828L supramarginal gyrus 
   3.56–58–208L superior temporal gyrus 
   3.54–38–2012L insula 
 3,670<0.0013.8150–1826R supramarginal gyrus 
   3.6850–8–10R superior temporal gyrus 
   3.645648R rolandic operculum 
a
All results were p<0.05, cluster-level family-wise error corrected, with an initial height threshold of p=0.01, uncorrected. CU=cocaine users; HC=healthy control subjects; MNI=Montreal Neurological Institute.
b
Corrected for the volume of the right amygdala, ppeak voxel<0.05.
c
Significant positive correlation.
d
Nonsignificant relation.
e
Significant negative correlation.
In addition, conditioned skin conductance responses and conditioned neural responses were significantly correlated across subjects (see Table S2 in the data supplement). An interaction analysis showed that the correlation between the skin conductance response and activity of the right amygdala and several regions within the prefrontal cortex was significantly different between groups (Figure 2C, Table 2). Follow-up tests showed a significant positive correlation in cocaine users but not in control subjects.

Extinction learning.

During early and late extinction, the CS+>CS− contrast was associated with significant activation of the insula, dorsomedial prefrontal cortex, and supramarginal gyrus. The CS−>CS+ contrast was associated with significant activation of the ventromedial prefrontal cortex, the superior and middle frontal cortex, and several regions within the occipital and temporal cortices (see Table S1 in the data supplement). There were no significant between-group differences during early extinction. However, during late extinction, cocaine users showed reduced activation in the dorsomedial prefrontal cortex compared with controls (Figure 3A, Table 2). This suggests that cocaine users exhibit enhanced extinction of dorsomedial prefrontal cortex fear responses.
FIGURE 3. Neural Correlates of Extinction Learning and Correlation With Skin Conductance Responses in Cocaine Users and Control Subjectsa
a Cocaine users exhibited hypoactivation of the dorsomedial prefrontal cortex during late extinction (panel A). They also exhibited significantly stronger negative correlations between activation of the ventromedial prefrontal cortex (Montreal Neurological Institute coordinates [x, y, z]: 10, 44, −8) and skin conductance responses during early extinction (panel B) and significantly stronger positive correlations between activation of the neural fear network, including the left insula (coordinates: −38, −28, −12) and skin conductance responses during late extinction (panel C). The scatterplot shows, for all subjects, the beta weights of the peak voxel resulting from the whole brain analysis against the skin conductance responses during early and late extinction.
Similar to the findings obtained during conditioning, an interaction analysis showed that the correlation between the skin conductance response and activity of the ventromedial prefrontal cortex and the parietal cortex was significantly different between groups during early extinction (Figure 3B, Table 2). Within-group analyses showed a significant negative correlation in cocaine users but not in control subjects. In addition, the correlation between skin conductance response and activation in the insula, left amygdala, and left and right superior temporal gyrus was significantly different between groups during late extinction (Figure 3C, Table 2). Within-group analysis showed a significant positive correlation in cocaine users but not in control subjects. These results suggest that reduced fear expression on a physiological level is related to enhanced ventromedial prefrontal cortex activity and reduced dorsomedial prefrontal cortex activity.

The Effect of State Anxiety and Polysubstance Use

To explore the effects of the level of substance use, light and heavy users of cocaine, cannabis, alcohol, and nicotine were compared. The neural correlates of aversive conditioning were unrelated to state anxiety, the amount and type of substance (cocaine, cannabis, alcohol, and nicotine) used, or days since last use. During extinction learning, there was a negative relation between the amount of cannabis used and responsiveness of the superior temporal, middle temporal, and inferior frontal cortex and a positive relation between the amount of cocaine used and responsiveness of the left insula, lateral prefrontal cortex, and parietal and occipital cortices (see Figure S3A,B and Table S3 in the data supplement). Nicotine and alcohol use were unrelated to the neural correlates of extinction learning. Regression analysis showed that state anxiety was negatively correlated with activation of the cerebellum during late extinction (see Figure 3C and Table S3).

Discussion

Although aversive conditioning and extinction learning have been suggested to play an important role in the development and persistence of drug abuse (5, 14, 24), this is, to our knowledge, the first study addressing the physiological and neural mechanisms underlying aversive conditioning and extinction learning in substance use disorder. Consistent with the hypothesis of enhanced aversive conditioning in substance use disorder, cocaine users showed hyperactivity of the amygdala and insula during aversive conditioning compared with control subjects. Inconsistent with the hypothesis of impaired extinction learning, cocaine users showed hypoactivation of the dorsomedial prefrontal cortex during late extinction, suggesting enhanced extinction learning compared with control subjects.
While there were no group differences in skin conductance response during aversive conditioning or extinction learning, skin conductance response and activation of the neural fear network were more strongly correlated across subjects in cocaine users than in control subjects, suggesting that the emotional response to conditioned stimuli is stronger in cocaine users than in control subjects. Overall, these findings support the postulated role of abnormal aversive learning processes in substance use disorder.
The amygdala is important for the rapid encoding of new stimulus-threat relationships (22), while the insula modulates the visceral response to conditioned stimuli (24). The dorsomedial prefrontal cortex is suggested to be involved in conscious negative appraisal of threat. These brain regions are key structures within a neural fear network, and previous studies have repeatedly demonstrated that activation of these regions is associated with fear conditioning and extinction learning (22), is enhanced in individuals with enhanced fear learning and impaired extinction learning (25), and is related to other measures of conditioned behavior, including skin conductance response (20). The finding of increased amygdala and insula activation during fear conditioning and reduced dorsomedial prefrontal cortex activation during late extinction in cocaine users therefore suggests that cocaine users exhibit enhanced fear conditioning as well as enhanced extinction learning compared with control subjects.
Increased amygdala activity in cocaine users during early conditioning may reflect increased attention for threat-related stimuli and enhanced aversive conditioning, followed by increased activity of the insula during late conditioning, which may reflect enhanced visceral processing. Increased responsiveness of these structures within the neural fear network are thought to underlie negative reinforcement mechanisms in substance use disorder, stress-induced relief craving, and subsequent continuation of or relapse into drug use (13, 18, 24, 33). Abnormalities in the neural underpinnings of aversive conditioning in cocaine users may therefore reflect a risk for cocaine abuse and relapse.
In contrast to our hypotheses, cocaine users showed reduced activity of the dorsomedial prefrontal cortex during late extinction, suggesting the presence of superior, and not impaired, extinction learning. While enhanced fear extinction learning may be beneficial in anxiety disorders, it may actually form a risk for the persistence of drug use, as it may underlie an inability to modify behavior in response to negative outcomes, resulting in risky behavior (34). Future studies should, however, investigate whether these difference are also present after reinstatement of the fear conditioned response. Irrespective of whether enhanced extinction of neural fear conditioned responses is good or bad, our data demonstrate that the neural underpinnings of fear extinction learning in cocaine users differ from those in patients with an anxiety disorder (16, 21, 22, 27, 35). While the relation between enhanced fear extinction learning and stress relief craving remains to be investigated, these findings may explain why cue exposure treatment, which is a successful treatment strategy in anxiety disorders, is not as effective in addiction (6).
In line with the typical observation in anxiety disorders, we found no group differences in differential skin conductance responses (16, 26, 27). Although these results could be interpreted as less efficient neural processing in cocaine users, there is substantial evidence that hyperactivation of the amygdala, insula, and dorsomedial prefrontal cortex reflects the persistence of an increased expression of conditioned fear (22). However, there are several other explanations for the dissociation between the skin conductance response and fMRI results. First, differential skin conductance responses are suggested to be more dependent on higher cognitive levels of learning, whereas differential activation of the neural fear network is suggested to be independent of higher cognitive processing (20). This would suggest that cocaine abuse is associated with abnormalities in fear conditioning and fear extinction that are mainly dependent on unconscious processes. Furthermore, the finding that the skin conductance response and fMRI data are significantly correlated in cocaine users but not in control subjects may indicate that skin conductance responses in cocaine users are less dependent on conscious processing of conditioned cues. Alternatively, it has demonstrated that the amygdala plays a critical role in the modulation of skin conductance responses to threat (36). Therefore, these results may indicate that cocaine users have a stronger emotional response to stimuli that predict an aversive outcome. In addition, several studies in anxiety disorders found that although there were no group differences in skin conductance responses during fear conditioning or extinction learning, differences were present during extinction recall (27). Thus, it could be that differences in neural processing precede differences in skin conductance responses, which can be detected only during extinction recall. Altogether, skin conductance responses may not be sensitive and fear-specific enough to detect small group differences during fear conditioning or extinction learning (37).
While sensitivity to stress has long been known to be an important risk factor for substance use and relapse (12), this is one of the first studies to investigate the potential neural mechanisms that underlie this phenomenon. We demonstrated that the neural fear network of regular cocaine users is hyperresponsive to cues that predict a negative outcome. These findings emphasize that in addition to reducing drug-conditioned responses (reward craving), treatment should also try to reduce the (neural) sensitivity to stressors (relief craving). This could be achieved by means of cognitive-behavioral treatment (e.g., mindfulness-based relapse prevention [38]) or pharmaceutical treatments that target the noradrenergic stress system (e.g., propranolol [39]).
An important strength of this study is the large sample size and the assessment of the potential confounding effect of state anxiety. However, the study also has limitations. First, because only male participants were included in the study, these results may not generalize to female cocaine users. Second, because of the cross-sectional design, we need to be cautious with statements about the causality of our findings, and future studies should examine whether increased neural sensitivity for aversive events is a risk factor for cocaine abuse, a consequence of cocaine abuse, or a combination of the two. Third, most cocaine users in our sample also used cannabis, alcohol, and nicotine on a regular basis, thereby making it impossible to tell whether differences in aversive conditioning are related to cocaine, cannabis, or alcohol use or to some combination of these. Nevertheless, the exploratory analysis suggested that hyperresponsiveness of the amygdala and insula during aversive conditioning and hyporesponsiveness of the dorsomedial prefrontal cortex during late extinction learning are independent of the type or amount of substance used. Moreover, as polysubstance use is common among cocaine users in treatment (1), we expect that our sample reflects typical cocaine users. Fourth, we tested for group differences during early and late conditioning, as well as early and late extinction, while there was no phase-by-group interaction effect. Although this is in accordance with most studies in the field (22), it should be noted that such statistical flexibility could increase type I errors. Finally, while the neural pathways that underlie aversive and appetitive conditioning and extinction overlap, more research is needed to investigate whether and how enhanced neural sensitivity to aversive conditioned cues and enhanced sensitivity to drug-conditioned cues are related.
In summary, we found that cocaine use disorder is associated with hyperresponsiveness of the neural fear network during fear conditioning and extinction learning, possibly reflecting enhanced fear learning. Although the relationship between aversive conditioning and stress-induced relief craving remains to be investigated, this study is an important contribution to the understanding of the role of aversive conditioning in, and the etiology of, substance use disorder.

Supplementary Material

File (appi.ajp.2016.15040433.ds001.pdf)

References

1.
European Monitoring Center for Drugs and Drug Addiction: Annual Report 2012: The State of the Drug Problem in Europe. Luxembourg, Publications Office of the European Union, 2012
2.
Potenza MN, Sofuoglu M, Carroll KM, et al: Neuroscience of behavioral and pharmacological treatments for addictions. Neuron 2011; 69:695–712
3.
Dutra L, Stathopoulou G, Basden SL, et al: A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165:179–187
4.
Everitt BJ: Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories: indications for novel treatments of addiction. Eur J Neurosci 2014; 40:2163–2182
5.
Milton AL, Everitt BJ: The persistence of maladaptive memory: addiction, drug memories, and anti-relapse treatments. Neurosci Biobehav Rev 2012; 36:1119–1139
6.
Kaplan GB, Heinrichs SC, Carey RJ: Treatment of addiction and anxiety using extinction approaches: neural mechanisms and their treatment implications. Pharmacol Biochem Behav 2011; 97:619–625
7.
Everitt BJ, Belin D, Economidou D, et al: Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 2008; 363:3125–3135
8.
Koob GF: Brain stress systems in the amygdala and addiction. Brain Res 2009; 1293:61–75
9.
Abraham AD, Neve KA, Lattal KM: Dopamine and extinction: a convergence of theory with fear and reward circuitry. Neurobiol Learn Mem 2014; 108:65–77
10.
Potenza MN, Hong KIA, Lacadie CM, et al: Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence. Am J Psychiatry 2012; 169:406–414
11.
Sinha R, Lacadie C, Skudlarski P, et al: Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology (Berl) 2005; 183:171–180
12.
Verheul R, van den Brink W, Geerlings P: A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol 1999; 34:197–222
13.
Koob GF: Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry 2009; 42(suppl 1):S32–S41
14.
Weiss F: Neurobiology of craving, conditioned reward, and relapse. Curr Opin Pharmacol 2005; 5:9–19
15.
Holmes A: G2B Reviews: stress at the intersection of anxiety, addiction, and eating disorders. Genes Brain Behav 2015; 14:1–3
16.
Lissek S, Powers AS, McClure EB, et al: Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther 2005; 43:1391–1424
17.
Weiss F, Ciccocioppo R, Parsons LH, et al: Compulsive drug-seeking behavior and relapse: neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci 2001; 937:1–26
18.
Sinha R: Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 2008; 1141:105–130
19.
Boschloo L, Vogelzangs N, Smit JH, et al: Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord 2011; 131:233–242
20.
Tabbert K, Stark R, Kirsch P, et al: Dissociation of neural responses and skin conductance reactions during fear conditioning with and without awareness of stimulus contingencies. Neuroimage 2006; 32:761–770
21.
Milad MR, Quirk GJ: Fear extinction as a model for translational neuroscience: ten years of progress. Annu Rev Psychol 2012; 63:129–151
22.
Sehlmeyer C, Schöning S, Zwitserlood P, et al: Human fear conditioning and extinction in neuroimaging: a systematic review. PLoS One 2009; 4:e5865
23.
Peters J, Kalivas PW, Quirk GJ: Extinction circuits for fear and addiction overlap in prefrontal cortex. Learn Mem 2009; 16:279–288
24.
Paulus MP, Stewart JL: Interoception and drug addiction. Neuropharmacology 2014; 76(Pt B):342–350
25.
VanElzakker MB, Dahlgren MK, Davis FC, et al: From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders. Neurobiol Learn Mem 2014; 113:3–18
26.
Milad MR, Pitman RK, Ellis CB, et al: Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry 2009; 66:1075–1082
27.
Milad MR, Furtak SC, Greenberg JL, et al: Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit. JAMA Psychiatry 2013; 70:608–618
28.
Sheehan DV, Lecrubier Y, Sheehan KH, et al: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20):22–33
29.
Sobell LC, Sobell MB: Timeline follow-back: a technique for assessing self-reported alcohol consumption, in Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Edited by Litten RZ, Allen JP. New York, Humana Press, 1992, pp 41–72
30.
Spielberger CD: Assessment of state and trait anxiety: conceptual and methodological issues. South Psychol 1985; 2:6–16
31.
Schmand B, Bakker D, Saan R, et al: [The Dutch Reading Test for Adults: a measure of premorbid intelligence level]. Tijdschr Gerontol Geriatr 1991; 22:15–19 (Dutch)
32.
Icenhour A, Kattoor J, Benson S, et al: Neural circuitry underlying effects of context on human pain-related fear extinction in a renewal paradigm. Hum Brain Mapp 2015; 36:3179–3193
33.
Sinha R, Li CSR: Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev 2007; 26:25–31
34.
Stephens DN, Ripley TL, Borlikova G, et al: Repeated ethanol exposure and withdrawal impairs human fear conditioning and depresses long-term potentiation in rat amygdala and hippocampus. Biol Psychiatry 2005; 58:392–400
35.
Rougemont-Bücking A, Linnman C, Zeffiro TA, et al: Altered processing of contextual information during fear extinction in PTSD: an fMRI study. CNS Neurosci Ther 2011; 17:227–236
36.
Wood KH, Ver Hoef LW, Knight DC: The amygdala mediates the emotional modulation of threat-elicited skin conductance response. Emotion 2014; 14:693–700
37.
Lonsdorf TB, Golkar A, Lindström KM, et al: BDNFval66met affects neural activation pattern during fear conditioning and 24 h delayed fear recall. Soc Cogn Affect Neurosci 2015; 10:664–671
38.
Bowen S, Witkiewitz K, Clifasefi SL, et al: Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry 2014; 71:547–556
39.
Kampman KM, Dackis C, Lynch KG, et al: A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend 2006; 85:129–137

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1033 - 1042
PubMed: 27079132

History

Received: 7 April 2015
Revision received: 16 October 2015
Revision received: 28 December 2015
Accepted: 29 January 2016
Published online: 15 April 2016
Published in print: October 01, 2016

Authors

Details

Anne Marije Kaag, M.Sc.
From the Departments of Psychiatry and Radiology, Academic Medical Center, Amsterdam; the Spinoza Center for Neuroimaging, Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam; Amsterdam Brain and Cognition, University of Amsterdam, Amsterdam; and the Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.
Nina Levar, M.Sc.
From the Departments of Psychiatry and Radiology, Academic Medical Center, Amsterdam; the Spinoza Center for Neuroimaging, Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam; Amsterdam Brain and Cognition, University of Amsterdam, Amsterdam; and the Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.
Karlijn Woutersen, M.Sc.
From the Departments of Psychiatry and Radiology, Academic Medical Center, Amsterdam; the Spinoza Center for Neuroimaging, Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam; Amsterdam Brain and Cognition, University of Amsterdam, Amsterdam; and the Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.
Judith Homberg, Ph.D.
From the Departments of Psychiatry and Radiology, Academic Medical Center, Amsterdam; the Spinoza Center for Neuroimaging, Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam; Amsterdam Brain and Cognition, University of Amsterdam, Amsterdam; and the Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.
Wim van den Brink, Ph.D., M.D.
From the Departments of Psychiatry and Radiology, Academic Medical Center, Amsterdam; the Spinoza Center for Neuroimaging, Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam; Amsterdam Brain and Cognition, University of Amsterdam, Amsterdam; and the Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.
Liesbeth Reneman, Ph.D., M.D.
From the Departments of Psychiatry and Radiology, Academic Medical Center, Amsterdam; the Spinoza Center for Neuroimaging, Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam; Amsterdam Brain and Cognition, University of Amsterdam, Amsterdam; and the Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.
Guido van Wingen, Ph.D.
From the Departments of Psychiatry and Radiology, Academic Medical Center, Amsterdam; the Spinoza Center for Neuroimaging, Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam; Amsterdam Brain and Cognition, University of Amsterdam, Amsterdam; and the Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.

Notes

Address correspondence to Ms. Kaag ([email protected]).
Presented at the European College of Neuropsychopharmacology Workshop for Junior Scientists, Nice, France, March 17–20, 2015; and at the 2014 annual meeting of the Organization for Human Brain Mapping, Hamburg, Germany, June 8–12, 2014.

Competing Interests

Dr. van den Brink has served on advisory panels and/or as a speaker for Bioprojet, D&A Pharma, Lundbeck, Mundipharma, Novartis, Pfizer, Reckitt Benckiser/Indivior, and Teva. The other authors report no financial relationships with commercial interests.

Funding Information

ZonMw10.13039/501100001826: 91211002
Supported by grant 91211002 from ZonMW.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share